Building on the success of last year’s event, Oxford Global Conferences are proud to the present the 3rd Annual Cell Culture and Bioprocessing Congress, taking place on November 17 – 18, 2014 in London, United Kingdom. This Congress is an executive platform for over 170 experts working in cell line development, cell line engineering, up and downstream operations, fermentation and biologics production.
A huge increase in global demand for biopharmaceutical products has increased the value of the cell culture industry significantly in the past few years; it is poised to reach a worth of over $6 billion by 2018. This Congress brings together leading experts to discuss ways to support this growth and overcome industry-wide challenges, and will be supported by key industry solution providers like Merck Millipore, Eppendorf, UPM, Solentim and Hamilton. Problems to be discussed include cell line stability, cell line authentication, scale-up improvements, contamination control and increasing reliability and consistency between batches.
On Day One, our panel of experts will discuss the latest advances in cell line and process development. Topics will include transfection of primary and hard-to-transfect cells, novel tools for 3D cell culture, new technologies for media optimization, high throughput cell culture techniques, achieving high titre cell cultures, disposable technology and automated cell line processes.
Day Two of the event will include case studies covering the most important challenges in biological production. Presentations will address how to develop commercially suitable cell banks, improve manufacturing flexibility, standardize single-use technology, ensure successful technology transfer and optimise cell lines for manufacturing. Our panel of industry leaders will also discuss key advances in cell line development, including the genetic characterisation of cell lines using NGS, cell line authentication technologies, contamination prevention methods and innovative cell culture assays.
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 40 speakers will present a full conference programme covering the topics outlined below.
Cell Line Development
- Transfection of primary and hard-to-transfect cells
- Novel tools for 3D cell culture
- New technologies for media optimization
- Stem cell mixture purification
- High-throughput cell culture techniques
- Successful fermentation methods
- Increasing the efficiency of upstream processes
- Integrating upstream and downstream processing
- Novel downstream processing platforms
- High-titre cell culture processes
- Process development case studies:
- Scale-up improvements
- Disposable bioreactors
- Automated cell line processes
Cell Line Development
- Cell line characterisation using NGS
- Cell line engineering for high expression levels
- Cell line selection
- Technologies for cell line authentication
- Methods for preventing contamination
- Techniques to improve the stability of cell lines
- Advanced cell culture assays
- Bio-manufacturing case studies:
- Gene therapies
- Viral vaccines
- Monoclonal antibodies
- Developing commercially suitable cell banks
- Improving manufacturing flexibility
- Standardization of single-use technology
- Ensuring successful technology transfer and process validation
- Optimizing cell lines for manufacturing
- Cécile Bauche – CSO, Theravectys
- Matthew Beard – Senior Principle Scientist, Ipsen
- Valentina Ciccarone – Principle Scientist, Macrogenics
- Ciska Dalm – Lead Scientist, Synthon
- David Danovi – Director, HipSci Cell Phenotyping, Centre for Stem Cells and Regenerative Medicine, King’s College London
- Patrik Froech – Head of Molecular Biology and Gene Expression, UCB
- Adam Goldstein – Senior Manager, Purificatio, Genentech
- John Harrington – Executive Vice President and Chief Scientific Officer, Athersys
- Philip Hass – Senior Scientific Manager, Genentech
- Chris Hewitt – Professor of Biological Engineering, Director of the DTC in Regenerative Medicine, Loughborough University
- Sven Kili – Senior Director, Sanofi
- Dave Knop – Director, Process Development, Applied Genetics Technology Corporation.
- Hans-Peter Knopf – Senior Biologics Expert, Novartis
- Rashmi Korke-Kshirsagar – Associate Director, Biogen Idec
- Luc Kupers – Program Manager Global Cell Cuture Media Strategy, Genzyme, a Sanofi company
- Lada Laenen – Managing Principal Scientist, Genzyme
- Nicolas Mermod – Professor, University of Lausanne
- Alvin Nienow – Emeritus Professor of Biochemical Engineering, University of Birmingham
- Anne Ramne – Senior Research Scientist, AstraZeneca
- Ulrich Ruemenapp – Head of Biotechnology Projects, Bayer
- Manfred Schuster – COO, Apeiron Biologics
- Lance Wong – Director, Process Development, Bavarian Nordic
- Jianxin Ye – Principal Scientist, Merck
Submit a poster
For attendees interested in submitting a poster, there are opportunities now available. Your poster presentation will be located in the exhibition room for two days alongside other posters from senior scientists working in industry and academia.
We will require:
- Poster title, Abstract (200 words or less)
- Principal author, Organisation, Mailing address
- Email, Telephone, Fax
- Additional authors
In order to secure your board space a fee of £250 plus VAT will be required. The poster should be presented as A0 (841mm x 1189mm) portrait size.
To take advantage of this opportunity you need to be registered as a paid delegate over the 2 days. We have limited spaces available, so please register soon!